ABSTRACT
Objectives: This study was planned to evaluate the perspectives, experiences, and methods followed by physicians on the treatment and management of COVID-19 infection, which affects the whole world. Method(s): In this study, in which physicians were included in the study, a questionnaire consisting of 21 questions was conducted in the electronic environment. The questionnaire questions included the treatment methods applied by the physicians during the COVID-19 pandemic, the guidelines they followed and their own clinical experiences. Result(s): Our study was conducted with a total of 200 physicians, 72 (36.0%) men and 128 (64.0%) women. The mean age of the physicians was 36.54+/-7.40 years. In the management and treatment of COVID-19 patients, 78.5% of the participants preferred to use the Ministry of Health's COVID-19 Outbreak Management and Study Guide (MHCOMSG) and 60.5% preferred to use the current international guidelines. In the oxygen support management of hypoxemic patients, 53.5% of the participants preferred to follow their personal experience and experience, 52.5% of them preferred to follow the MHCOMSG, 51% of them preferred to follow the current international guidelines. There is a statistically significant relationship between the duration of professional experience, the institution where the employee is working and treatment management preferences. Conclusion(s): During the COVID-19 pandemic process, physicians preferred to follow the MHCOMSG in treatment and patient management. It is important for health-care professionals to follow new developments closely and to make updates on COVID-19 published online by official government health officials in terms of health workers' preferences in accessing information.Copyright © Telif hakki 2022 Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi - Available online at www.gkdaybd.org.
ABSTRACT
Objectives: This study was planned to evaluate the perspectives, experiences, and methods followed by physicians on the treatment and management of COVID-19 infection, which affects the whole world. Method(s): In this study, in which physicians were included in the study, a questionnaire consisting of 21 questions was conducted in the electronic environment. The questionnaire questions included the treatment methods applied by the physicians during the COVID-19 pandemic, the guidelines they followed and their own clinical experiences. Result(s): Our study was conducted with a total of 200 physicians, 72 (36.0%) men and 128 (64.0%) women. The mean age of the physicians was 36.54+/-7.40 years. In the management and treatment of COVID-19 patients, 78.5% of the participants preferred to use the Ministry of Health's COVID-19 Outbreak Management and Study Guide (MHCOMSG) and 60.5% preferred to use the current international guidelines. In the oxygen support management of hypoxemic patients, 53.5% of the participants preferred to follow their personal experience and experience, 52.5% of them preferred to follow the MHCOMSG, 51% of them preferred to follow the current international guidelines. There is a statistically significant relationship between the duration of professional experience, the institution where the employee is working and treatment management preferences. Conclusion(s): During the COVID-19 pandemic process, physicians preferred to follow the MHCOMSG in treatment and patient management. It is important for health-care professionals to follow new developments closely and to make updates on COVID-19 published online by official government health officials in terms of health workers' preferences in accessing information.Copyright © Telif hakki 2022 Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi - Available online at www.gkdaybd.org.
ABSTRACT
Elderly patients are at high risk of corona virus disease 2019 (COVID-2019) infection and severe COVID-19 patients are treated in intensive care units (ICU). Drug-drug interaction risk increased to 100% with eight or more medication use. Comorbidities in both elderly and ICU patients leading to polypharmacy and a higher risk for drug-drug interactions. Also, the organ dysfunctions due to COVID-19 may alter the pharmacokinetics of the drugs which may influence the severity of drug interactions. The severity, mechanisms, onset of action and clinical significance of the drug-drug interactions may vary. Detailed information on COVID-19 drug interactions is reported by The Liverpool Drug Interaction Group, however this paper was aimed to provide a quick guidance on these interactions for the clinicians. During the management of COVID-19, possibility of drug-drug interactions should be considered by clinicians to avoid any negative outcomes in the treatment process.